Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06583408 · ClinicalTrials.gov registry record
The REgistry of Very Early Estrogen and AnovuLation
A clinical trial of Hypothalamic Amenorrhea and Hypothalamic Amenorrhea, Functional, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 2
- Study locations
NCT06583408 is a study of Hypothalamic Amenorrhea and Hypothalamic Amenorrhea, Functional that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100,000 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06583408, a study of Hypothalamic Amenorrhea and Hypothalamic Amenorrhea, Functional, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.
Conditions Studied
Interventions
- OTHER Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24)
- OTHER REVEAL Questionnaire
Study Locations (2)
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2029-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06583408
The ClinicalTrials.gov registry entry for NCT06583408 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hypothalamic Amenorrhea appearing as the primary indexed condition, and to 2 interventions - of which Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24) is the first listed.
NCT06583408 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06583408 about?
NCT06583408 is a clinical study titled "The REgistry of Very Early Estrogen and AnovuLation". The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.
What is the current status of trial NCT06583408?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2024-07-01. Estimated completion is 2029-08-01.
What conditions does trial NCT06583408 study?
This clinical trial studies the following conditions: Hypothalamic Amenorrhea, Hypothalamic Amenorrhea, Functional, Functional Hypogonadotropic Hypogonadism.
What interventions are being tested in trial NCT06583408?
The interventions under investigation include: Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24) (OTHER), REVEAL Questionnaire (OTHER).
Who is sponsoring clinical trial NCT06583408?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06583408 being conducted?
This trial has 2 study locations across Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypothalamic Amenorrhea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.